Department of Family Medicine, Oregon Health and Science University (OHSU), Portland, Oregon, USA.
Research Department, OCHIN, Inc, Portland, Oregon, USA.
J Am Geriatr Soc. 2022 Mar;70(3):854-861. doi: 10.1111/jgs.17589. Epub 2021 Dec 2.
National reports suggest that Hispanic patients may underutilize influenza and pneumococcal vaccination, although studies sometimes conflict on this point. A clearer picture of adult immunization utilization in older Hispanic patients is necessary to ensure equity in adult vaccinations.
Using electronic health records from 648 community health centers (CHCs) across 21 states, we compared English-preferring Hispanic patients, Spanish-preferring Hispanic patients, and Non-Hispanic White (NHW) adults aged ≥50 years across five outcomes between 2012-2017: (1) Odds of ever receiving pneumococcal vaccination after age 65, (2) Odds of ever receiving ≥2 pneumococcal vaccinations for those ≥65, (3) odds of vaccination between the ages of 50 and 64 for those with diabetes or heart disease, (4) odds of influenza vaccine, and (5) annual rate of influenza vaccination.
Of our total study sample (N = 143,869), 85,562 were age 50-64 during the entire study period, and 65,977 were ≥65 at some point during the study period. In patients aged 50-64, Spanish-preferring Hispanic patients were more likely to have ever had an influenza vaccination (covariate-adjusted odds ratio [aOR] = 1.33, 95% CI = 1.29-1.37), had higher rates of annual influenza vaccination (covariate-adjusted rate ratio [aRR] = 1.41, 95% CI = 1.38-1.44), and higher odds of pneumococcal vaccination (aOR = 1.87, 95% CI = 1.76-1.98) than NHW patients. These findings were similar in Spanish-preferring Hispanic patients ≥65. English-preferring Hispanics ≥65 were less likely than NHW patients to ever have an influenza vaccination (aOR = 0.91, 95% CI = 0.85-0.98) and to have ever received at least one (aOR = 0.92, 95% CI = 0.86-0.99) or two (aOR = 0.86, 95% CI = 0.77-0.95) pneumococcal vaccine doses.
In a multistate CHC network, Spanish-preferring Hispanic patients were more likely to receive influenza and pneumococcal vaccinations than NHW patients; older English-preferring Hispanic patients were often less likely than NHW patients to receive these vaccinations. In vaccine initiatives, English-preferring Hispanic patients may be at higher risk of vaccination inequity.
国家报告表明,西班牙裔患者可能未充分利用流感和肺炎球菌疫苗接种,尽管有些研究对此存在争议。为了确保成人疫苗接种的公平性,有必要更清楚地了解老年西班牙裔患者的成人免疫接种利用情况。
我们使用来自 21 个州的 648 个社区卫生中心(CHC)的电子健康记录,比较了在五个结果方面,2012-2017 年间,英语偏好的西班牙裔患者、西班牙语偏好的西班牙裔患者和非西班牙裔白人(NHW)≥50 岁的成年人:(1)65 岁以后接受肺炎球菌疫苗接种的几率;(2)≥65 岁的人接受≥2 次肺炎球菌疫苗接种的几率;(3)患有糖尿病或心脏病的人在 50-64 岁之间接种疫苗的几率;(4)流感疫苗接种率;(5)流感疫苗接种的年度比率。
在我们的总研究样本(N=143869)中,85562 人在整个研究期间年龄在 50-64 岁之间,65977 人在研究期间的某个时候年龄≥65 岁。在 50-64 岁的患者中,西班牙语偏好的西班牙裔患者更有可能接受过流感疫苗接种(调整后的优势比[aOR]为 1.33,95%置信区间[CI]为 1.29-1.37),接受年度流感疫苗接种的比率更高(调整后的比率比[aRR]为 1.41,95%CI 为 1.38-1.44),并且肺炎球菌疫苗接种的几率更高(调整后的优势比[aOR]为 1.87,95%CI 为 1.76-1.98)比 NHW 患者。在≥65 岁的西班牙语偏好的西班牙裔患者中,这些发现是相似的。≥65 岁的英语偏好的西班牙裔患者比 NHW 患者更不可能接受流感疫苗接种(调整后的优势比[aOR]为 0.91,95%CI 为 0.85-0.98),并且接受过至少一剂(调整后的优势比[aOR]为 0.92,95%CI 为 0.86-0.99)或两剂(调整后的优势比[aOR]为 0.86,95%CI 为 0.77-0.95)肺炎球菌疫苗的可能性也较低。
在一个多州 CHC 网络中,西班牙语偏好的西班牙裔患者比 NHW 患者更有可能接种流感和肺炎球菌疫苗;年龄较大的英语偏好的西班牙裔患者往往比 NHW 患者更不可能接种这些疫苗。在疫苗接种计划中,英语偏好的西班牙裔患者可能面临更大的疫苗接种不平等风险。